Beckman Coulter Diagnostics, a clinical diagnostics leader, today introduces the new DxC 500i Clinical Analyzer*, an integrated clinical chemistry and immunoassay analyzer. As healthcare systems ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k ...

Beckman Coulter aims to expand its reach in accessible diagnostic tests for Alzheimer’s disease, to get ahead of potentially high demand as advancements are made in hopefully treating the ...

Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up to 25 million per month by March. The Access antigen assay is designed for ...

Under an existing BNP Supply Agreement, Quidel provides Beckman Coulter with antibodies and certain other components, and Beckman Coulter acts as Quidel’s contract manufacturer for the BNP assay ...

In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal antibody-based Alzheimer’s disease therapeutics.

Nearly two months after rumors swirled that Brea, California-based Beckman Coulter was looking at buyout offers, the company has agreed to be purchased in a deal valued at $6.8 billion. The ...

Northern Colorado is getting a bigger presence from Beckman Coulter Life Sciences. The Fortune 500 bioscience precision instruments manufacturer will open a new facility, bringing 85 new jobs. They… ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces the Next-Generation Basophil Activation Test (BAT) for research use only to more effectively ...

Conceding that the days of massive punitive damage awards may be over, Beckman Coulter Inc. on Wednesday settled its fraud and breach-of-contract lawsuit against Flextronics International Ltd. for ...

Danaher (DHR) said today it has agreed to acquire Beckman Coulter (BEC) for $83. 50 per share, or a total value of $6.